AI Article Synopsis

  • TRAF1 is distinct from other TRAF family members because it doesn't have the typical RING/zinc-finger domain, and its specific functions remain uncertain due to conflicting research findings.
  • TRAF1 has been shown to interact with the BAFF receptor and enhance the activation of the alternative NF-kappaB signaling pathway by stabilizing NIK and promoting the conversion of p100 to its mature form, p52.
  • Reducing TRAF1 levels in a Hodgkin's disease cell line disrupts p100 processing and affects gene transcription linked to p52, indicating that TRAF1 is a key positive regulator in this pathway.

Article Abstract

Tumor necrosis factor receptor-associated factor 1 (TRAF1) is unique among the members of the TRAF family, as it lacks the N-terminal RING/zinc-finger domain. Also the function of TRAF1 is not clearly established, with many papers reporting contradictory results. Here we show that TRAF1 interacts with BAFF receptor, a member of the TNF receptor family, and positively regulates activation of the alternative NF-kappaB pathway. Ectopic expression of TRAF1 causes degradation of TRAF3, stabilization of NIK, and processing of p100 to produce the mature form p52. In addition, we show that knocking-down expression of TRAF1 in the Hodgkin's disease derived cell line L1236, interfere with p100 processing and with p52 mediate gene transcription. Collectively these results support a role for TRAF1 as a positive regulator of the NF-kappaB alternative pathway.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.molimm.2009.07.029DOI Listing

Publication Analysis

Top Keywords

receptor-associated factor
8
positive regulator
8
regulator nf-kappab
8
nf-kappab alternative
8
alternative pathway
8
expression traf1
8
traf1
6
tnf receptor-associated
4
factor positive
4
pathway tumor
4

Similar Publications

We identified a rare heterozygous germline loss-of-function variant in the tumor necrosis factor receptor-associated factor 2 (TRAF2) in a young adult patient diagnosed with medulloblastoma. This variant is located within the TRAF-C domain of the E3 ubiquitin ligase protein and is predicted to diminish the binding affinity of TRAF2 to upstream receptors and associated adaptor proteins. Integrative genomics revealed a biallelic loss of TRAF2 via partial copy-neutral loss-of-heterozygosity of 9q in the medulloblastoma genome.

View Article and Find Full Text PDF

Chemoresistance poses a significant clinical challenge in the treatment of gastric cancer (GC), while its underlying molecular mechanisms are still not fully understood. Post-translational protein modification and abnormal activation of nuclear factor-kappa B (NF-κB) are critical regulators of tumor chemoresistance. This study investigates the role of TNF receptors-associated factors 6 (TRAF6) in 5-Fluorouracil (5-FU) resistant GC.

View Article and Find Full Text PDF

The cGAS-STING pathway activates transcription factor TFEB to stimulate lysosome biogenesis and pathogen clearance.

Immunity

December 2024

Department of Thoracic Surgery of Sir Run Run Shaw Hospital, and Department of Biochemistry, Zhejiang University School of Medicine, Hangzhou 310058, Zhejiang, China. Electronic address:

Induction of autophagy is an ancient function of the cyclic GMP-AMP (cGAMP) synthase (cGAS)-stimulator of interferon genes (STING) pathway through which autophagic cargoes are delivered to lysosomes for degradation. However, whether lysosome function is also modulated by the cGAS-STING pathway remains unknown. Here, we discovered that the cGAS-STING pathway upregulated lysosomal activity by stimulating lysosome biogenesis independently of the downstream protein kinase TANK-binding kinase 1 (TBK1).

View Article and Find Full Text PDF

Tumor necrosis factor receptor-associated factor (TRAF) proteins, originally identified in mammals, have since been found in most plants. TRAF proteins in plants have been shown to be involved in cellular autophagy, immunity, drought resistance, and ABA induction. However, the role in regulating sucrose and starch metabolism has not been reported.

View Article and Find Full Text PDF

In this study, we investigated the effects of tumor necrosis factor receptor-associated protein 1 (TRAP1) on aerobic glycolysis in cisplatin-resistant lung cancer cells and explored the underlying mechanism. TRAP1 expression levels were determined in cisplatin-resistant lung cancer tissues and A549/CDDP cells. Subsequently, TRAP1 expression in A549/CDDP cells was silenced via small interfering RNA transfection.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!